2,6-Difluorobenzonitrile

We are 2,6-Difluorobenzonitrile CAS:1897-52-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,6-Difluorobenzonitrile
CAS.NO:1897-52-5
Synonyms:2,6-Difluorobenzonitrile
2,6-difluoro-benzonitrile
Molecular Formula:C7H3F2N
Molecular Weight:139.10200
 
Physical and Chemical Properties:
Density:1.246
Melting point:25-28ºC
Boiling point:197-198ºC
Flash point:176°F
Index of Refraction:1.4875
 
Specification:
Appearance:Light yellow liquid
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Pesticide intermediates

2,6-Difluorobenzonitrile


Related News: Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.5-bromopentan-1-ol CAS:34626-51-2 The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.N-Methyl-4-nitroaniline This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.4-metil-3- (trifluorometil) anilina CAS:65934-74-9 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”

Related Products
Product Name
1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10-henicosafluoro-12-iodododecane Cas:2043-54-1 View Details
Heptafluoropropyl trifluorovinyl ether Cas:1623-05-8 View Details
2,2,3,4,4,4-HEXAFLUORO-1-BUTANOL Cas:382-31-0 View Details
Methyl 2-amino-4-((2,5-dichlorophenyl)carbamoyl)benzoate manufacturer 2-fluorobenzoic acid manufacturer 2-Bromo-6-nitroaniline manufacturer 1-bromodibenzo[b,d]furan manufacturer OBESTATIN (RAT) manufacturer